Published on 16/11/2025
Clinical Study Report TFLs: Designing, Programming, and Verifying Outputs That Regulators Trust
From Protocol to Pages: What Belongs in CSR TFLs and Why It Matters
Tables, figures, and listings (TFLs) are the visible record of a study’s results in the Clinical Study Report (CSR). They transform protocol objectives and Statistical Analysis Plan (SAP) rules into paginated, reproducible evidence. Global assessors—the U.S. FDA, the EMA, Japan’s PMDA, Australia’s TGA, and the public-health lens of the Purpose of each T/F/L type. Tables carry precise numbers (counts, estimates, confidence intervals) with footnotes and denominators; figures communicate patterns (e.g., Kaplan–Meier curves, forest plots, lab shift heatmaps); listings provide record-level transparency (patient narratives, protocol deviations, serious adverse events). Together, they must tell one coherent story: who was studied, what happened, how outcomes were analyzed, and how robust findings are. Core sections most programs include. Estimands drive presentation. If the primary estimand is treatment policy, tables should reflect outcomes regardless of rescue; if while-on-treatment, truncation rules and windows must be explicit. For survival estimands, figures should emphasize events and follow-up time; if non-proportional hazards are anticipated, include RMST/milestone displays alongside Cox results. Submission posture. TFLs live alongside the data standards package (SDTM/ADaM/define.xml) and programming specifications. The line of sight from CSR text → TFLs → ADaM → SDTM/source is as important as the numbers. Inspectors will attempt to regenerate key figures and tables using the analysis datasets; they must match within documented precision rules. Mock shells are contracts, not sketches. Each shell must define title, population (ITT/SAF/PP), denominator rules, row/column structure, sorting, precision, handling of zeros/NA, footnote text, abbreviations, and statistical methods (e.g., ANCOVA with baseline as covariate; stratified Cox with specified strata). Link every shell to a unique identifier and the SAP section that authorizes it. Precision and rounding. Adopt consistent, pre-declared rules (e.g., means to 1 decimal if SD <10, otherwise 2; proportions to 1 decimal; p-values to 3 decimals with “<0.001” floor; risks/HRs with 2–3 decimals). All derived values should be rounded only for presentation; internal computations use full precision. State significant-figure policy for PK and lab measures. Denominators and analysis sets. The shell must show the analysis population for each display: ITT for efficacy, SAF for safety, PP for supportive. Where denominators vary by visit (e.g., missed windows), show Controlled terminology and coding versions. Display MedDRA version for AE coding and WHO-DD for concomitant meds in table footnotes; include CTCAE version for grading, if used. Ensure the versions match those in define.xml and protocol/SAP. Mismatched versions are a common inspection finding. Style guide and reuse. A study or program style guide should standardize typography, indentation, column spacing, thousand separators, missing-value glyphs (e.g., “—”), hyphenation, and pagination behaviors (repeat headers, widow/orphan rules). Provide a component library (shell snippets, footnote library, standard abbreviations) to maximize reuse and reduce errors across studies. Traceability mapping. Include a mapping for each shell: ADaM dataset(s) and key variables used (e.g., ADSL for populations, ADLB for lab shifts, ADTTE for time-to-event). For complex derivations, attach a derivation block (pseudo-code) and reference program modules. The mapping allows a reviewer to move seamlessly from a cell value back to the precise analysis variable and derivation logic. Figures that inform. Standard figure shells include KM curves with risk tables, forest plots for subgroups (with interaction p-values), spaghetti plots for longitudinal outcomes, waterfall plots for tumor burden, and lab shift heatmaps. Define axis scales, censoring marks, confidence-band methods, and color accessibility. State whether arms are shown for blinded CSR drafts; final CSRs typically include arm labels after unblinding. Listings for transparency. Pre-define inclusion criteria for subject listings (e.g., all SAEs with onset relative to first dose, causality, outcome, MedDRA SOC/PT; all deaths; all discontinuation reasons; all major protocol deviations with impact). Protect privacy by masking direct identifiers and following minimum-necessary principles consistent with data-protection expectations in the U.S./EU/UK and the public-health guidance of the WHO. Inputs and lineage. TFLs must be generated from analysis datasets (ADaM), not directly from SDTM, to preserve derivation consistency. Maintain lineage manifests that show source SDTM domains, transformation steps, and the ADaM variables feeding each TFL. Ensure that define.xml describes variables, controlled terms, and derivations that match the code and shells. Automation that respects control. Use parameterized programs and macro libraries for repeatable structures (subject disposition, AE summaries, lab shifts). Build a table engine that enforces the style guide, pagination, and footnote logic uniformly. Guardrails matter—automate with validation, not instead of it. Double programming and peer review. For pivotal outputs (primary efficacy table, KM curve, top-level safety table), perform independent double programming by a second statistician/programmer using separate code. Compare at the dataset level and at the presentation level; mismatches must be reconciled with documented root cause and resolution. Quality checks that catch real issues. Reproducibility and versioning. Lock program versions, package/library versions, and random seeds (for simulation-based displays) in a controlled repository. Capture a point-in-time configuration snapshot (ADaM datasets, shells, code, style guide, macro versions) at each data cut and at CSR finalization. Archive artifacts in the TMF to facilitate regulator re-runs at the FDA, EMA, PMDA, and TGA. Blinding hygiene in production. If CSR drafts are produced before unblinding, generate arm-agnostic TFLs (e.g., Group A/B) and quarantine arm-labeled outputs to a restricted folder accessible only to unblinded roles. Keep access logs and approvals. After unblinding, regenerate only the labels; do not re-compute numbers unless a planned lock/refresh is approved. Output formats and pagination. CSRs typically require RTF/PDF with consistent pagination, repeating headers, and book-ready styles. Exports for health-technology assessments may need Excel/CSV companions. Ensure that page numbers, section anchors (e.g., 14.x series), and table/figure captions match the CSR and the table of contents. Avoid line wrapping that breaks n/N (%) columns or footnote references. Special domains—common pitfalls. Change control and auditability. Any post-lock change to shells or programs requires a controlled change record with impact assessment and approvals from statistics, QA, and clinical leads. Maintain an audit trail of who ran which program when, with dataset checksums, to reconstruct the exact state of outputs in case of questions. What reviewers ask for first. Prepare a “rapid-pull” index that surfaces within minutes: Quality indicators worth tracking. Common failure modes—and durable fixes. One-page checklist (study-ready TFLs). Bottom line. CSR TFLs are more than formatted numbers—they are a compliance artifact that encodes your SAP, standards, and quality system. When shells are explicit, mappings are transparent, programs are validated and reproducible, and outputs read consistently across the CSR, reviewers at the FDA, EMA, PMDA, and TGA can navigate quickly. Following the harmonized perspective of the ICH and the public-health mission of the WHO, these practices make your conclusions clearer and your submission stronger.
Blueprint Before Build: Mock Shells, Style Guides, and Traceability Rules
n/N (%) with N explicit per time point. For responder endpoints, define the responder rule and how missing/intercurrent events contribute (e.g., non-responder imputation under composite estimand).From Datasets to Deliverables: Programming, Validation, and Documented Controls
Inspection-Grade Confidence: Evidence Bundle, Metrics, Pitfalls, and a Practical Checklist